On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Centro de Investigación del Cáncer

InstitutionResearch output, impact & collaborations

Centro de Investigación del Cáncer is a institution indexed in ScholarIQ from OpenAlex.

What is known about Centro de Investigación del Cáncer?

ScholarIQrecord summary

Centro de Investigación del Cáncer is a research organisation in Salamanca, ES. OpenAlex records 5,488 works and 910,869 citations for it. 1,104 researchers list it as their most recent affiliation.

How many works does Centro de Investigación del Cáncer have?

ScholarIQindexed works

Centro de Investigación del Cáncer has 5,488 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Centro de Investigación del Cáncer →

How many citations does Centro de Investigación del Cáncer have?

ScholarIQcitation count

Centro de Investigación del Cáncer has 910,869 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Centro de Investigación del Cáncer →

How many researchers are at Centro de Investigación del Cáncer?

ScholarIQresearcher count

Centro de Investigación del Cáncer has 1,104 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Centro de Investigación del Cáncer?

ScholarIQavg h-index

Centro de Investigación del Cáncer has an average h-index of 52.5 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Centro de Investigación del Cáncer?

ScholarIQror

The ROR for Centro de Investigación del Cáncer is on the source record.

Open the ROR →

What is the OpenAlex record for Centro de Investigación del Cáncer?

ScholarIQopenalex

The OpenAlex for Centro de Investigación del Cáncer is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Centro de Investigación del Cáncer?

ScholarIQtop researchers by citations

Paul Reilly · Atrial Fibrillation Management and Outcomes

176 works26,747 citations

Pedro A. Lazo · Nuclear Structure and Function

219 works16,834 citations

What are the most-cited papers on Centro de Investigación del Cáncer?

ScholarIQmost cited works

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John W. Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Díaz, Basil S. Lewis, Harald Darius, Hans‐Christoph Diener, Campbell Joyner, Lars Wallentin

New England Journal of Medicine. 200911,232 CitationsOPEN ACCESS

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

Charles V. Pollack, Paul Reilly, Joanne van Ryn, John W. Eikelboom, Stephan Glund, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, CW Kam, Pieter W. Kamphuisen, Jörg Kreuzer, Jerrold H. Levy, Gordon Royle, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Peter Verhamme, Bushi Wang, Laura Young, Jeffrey I. Weitz

New England Journal of Medicine. 20171,144 CitationsOPEN ACCESS

Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis

Manuel Rodríguez‐Paredes, Alexia Martínez de Paz, Laia Simó‐Riudalbas, Sergi Sayols, Cátia Moutinho, Sebastián Morán, Alberto Villanueva, Marta Vázquez-Cedeira, Pedro A. Lazo, Fátima Carneiro, Conceição Souto Moura, Joana Vieira, Manuel R. Teixeira, Manel Esteller

Oncogene. 2013166 CitationsOPEN ACCESS

How much of the research on Centro de Investigación del Cáncer is open access?

ScholarIQopen access share

100%OPEN ACCESS

Gold

Green

Hybrid

33%

Bronze

67%

Closed